These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1481392)

  • 1. [The favorable effect of hydrolytic enzymes in the treatment of immunocytomas and plasmacytomas].
    Sakalová A; Mikulecký M; Holománová D; Langner D; Ransberger K; Stauder G; Mistrík M; Gazová S; Chabronová I; Benzová M
    Vnitr Lek; 1992 Sep; 38(9):921-9. PubMed ID: 1481392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of enzymes in treating patients with malignant lymphoma with a large tumor mass].
    Gubareva AA
    Lik Sprava; 1998 Aug; (6):141-3. PubMed ID: 9844901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Wobe-Mugos: a proteolytic enzyme combination for tumor therapy. Documentation No. 7].
    Schweiz Rundsch Med Prax; 1987 Dec; 76(51):1430-2. PubMed ID: 3326110
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme therapy in patients with advanced colorectal cancer.
    Popiela T; Kulig J; Kłek S; Wachol D; Bock PR; Hanisch J
    Przegl Lek; 2000; 57 Suppl 5():138-9. PubMed ID: 11202278
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind pilot-study on the efficacy of enzyme therapy in advanced colorectal cancer.
    Popiela T; Kulig J; Kłek S; Wachol D; Bock PR; Hanisch J
    Przegl Lek; 2000; 57 Suppl 5():142. PubMed ID: 11202281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local transrectal enzymatic treatment for chronic nonbacterial prostatitis and prostatodynia: initial clinical experience.
    Kerbl K; Zisch R
    Tech Urol; 2000 Mar; 6(1):22-5. PubMed ID: 10708143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of systemic enzyme therapy in combined treatment of patients with pulmonary cancer and malignant thymoma].
    Hanul VL; Smolanka II; Ponomar'ova OV
    Klin Khir; 2000 Jun; (6):17-9. PubMed ID: 11288269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enzyme therapy--an alternative in treatment of herpes zoster. A controlled study of 192 patients].
    Billigmann P
    Fortschr Med; 1995 Feb; 113(4):43-8. PubMed ID: 7713467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers--a clinical phase-III randomized trial.
    Kaul R; Mishra BK; Sutradar P; Choudhary V; Gujral MS
    Indian J Cancer; 1999; 36(2-4):141-8. PubMed ID: 10921218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic enzyme therapy with the preparation Wobe-Mugos E in the combined treatment of lung cancer patients].
    Smolanka II
    Lik Sprava; 2000; (5):121-3. PubMed ID: 11031472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the preparation Wobe-Mugos E on parameters of the antioxidant defence system and morphofunctional erythrocyte status in patients with chronic obstructive bronchitis].
    Kolomoiets' MIu; Kovalenko SV; Todoriko LD
    Lik Sprava; 2000 Sep; (6):100-4. PubMed ID: 11478274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial.
    Martin T; Uhder K; Kurek R; Roeddiger S; Schneider L; Vogt HG; Heyd R; Zamboglou N
    Radiother Oncol; 2002 Oct; 65(1):17-22. PubMed ID: 12413670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of the preparation Wobe-Mugos E on the functional and biochemical status of the kidneys in the polyuric stage of sublimate-induced nephropathy].
    Rohovyĭ IuIe; Myslyts'kyĭ VF; Filipova LO; Shapovalov VP; Mahalias MV; Maĭkan RI; Chortyk IuB
    Fiziol Zh (1994); 2000; 46(3):51-6. PubMed ID: 11059387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymes, trophoblasts, and cancer: the afterlife of an idea (1924-2008).
    Moss RW
    Integr Cancer Ther; 2008 Dec; 7(4):262-75. PubMed ID: 19116222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic enzymotherapy as a method of prophylaxis of postradiation complications in oncological patients].
    Hubarieva HO; Kindzel's'kyĭ LP; Ponomar'ova OV; Udatova TV; Shpil'ova SI; Smolanka II; Korovin SI; Ivankin VS
    Lik Sprava; 2000; (7-8):94-100. PubMed ID: 16786662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local therapy of malignant pleural effusions.
    Titscher R; Kokron O; Letnansky K
    Neoplasma; 1974; 21(4):465-9. PubMed ID: 4473732
    [No Abstract]   [Full Text] [Related]  

  • 17. Where do the immunostimulatory effects of oral proteolytic enzymes ('systemic enzyme therapy') come from? Microbial proteolysis as a possible starting point.
    Biziulevicius GA
    Med Hypotheses; 2006; 67(6):1386-8. PubMed ID: 16870353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme therapy in comparison with immune complex determinations in chronic polyarthritis].
    Steffen C; Smolen J; Miehlke K; Hörger I; Menzel J
    Z Rheumatol; 1985; 44(2):51-6. PubMed ID: 4050140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastases in mice.
    Wald M; Závadová E; Poucková P; Zadinová M; Boubelik M
    Life Sci; 1998; 62(3):PL43-8. PubMed ID: 9488106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy : results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study.
    Dörr W; Herrmann T;
    Strahlenther Onkol; 2007 Mar; 183(3):121-7. PubMed ID: 17340069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.